Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,467 | 58,064 | 378,021 | 88,980 | 344,709 |
| Marketable Securities | 211,474 | 222,767 | 127,255 | 259,586 | 156,387 |
| Receivables | 15,868 | 21,996 | 10,673 | 9,653 | 12,782 |
| Inventories | N/A | N/A | N/A | 16,830 | 12,220 |
| Other current assets | 74,173 | 31,310 | 5,422 | 0 | 0 |
| TOTAL | $393,341 | $338,488 | $532,823 | $378,749 | $528,503 |
| Non-Current Assets | |||||
| PPE Net | 16,422 | 12,644 | 13,176 | 10,157 | 8,460 |
| Investments And Advances | 12,750 | 4,985 | 11,869 | 41,587 | 99,565 |
| Other Non-Current Assets | 46,544 | 52,709 | 2,367 | 10,907 | 2,726 |
| TOTAL | $75,716 | $70,338 | $27,412 | $62,651 | $110,751 |
| Total Assets | $469,057 | $408,826 | $560,235 | $441,400 | $639,254 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 19,334 | 9,851 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,775 | 4,758 | 9,028 | 5,924 | 1,733 |
| Accrued Expenses | 45,260 | 38,233 | 26,889 | 24,136 | 14,021 |
| TOTAL | $123,571 | $111,703 | $98,554 | $62,552 | $49,268 |
| Non-Current Liabilities | |||||
| Long Term Debt | 372,873 | 219,300 | 229,535 | N/A | N/A |
| Deferred Revenues | 11,523 | 31,575 | 43,402 | 125 | 152 |
| Other Non-Current Liabilities | 276,016 | 294,902 | 249,580 | 258,566 | 235,789 |
| TOTAL | $649,237 | $520,963 | $513,270 | $263,670 | $239,755 |
| Total Liabilities | $772,808 | $632,666 | $611,824 | $326,222 | $289,023 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 64,328 | 62,520 | 55,580 | 54,381 | 52,855 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -1,526,617 | -1,248,600 | -1,012,145 | -797,740 | -512,225 |
| Other shareholders' equity | 47 | 145 | -166 | -733 | -253 |
| TOTAL | $-303,751 | $-223,840 | $-51,589 | $115,178 | $350,231 |
| Total Liabilities And Equity | $469,057 | $408,826 | $560,235 | $441,400 | $639,254 |